Definium Therapeutics to release Phase 3 MDD study results June 22

June 21, 2026 5:00 PM

Definium Therapeutics (NASDAQ: DFTX) announced it will host a webcast on June 22, 2026, at 8:00 a.m. EDT to discuss ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found